Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Damier

Showing results (71-80 of 107) with videos related to

Pageof 11
Sort By:
Neurobiology of Aging|June 5, 2012
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?Suzanne Lesage, Christel Condroyer, Stephan Klebe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over studyOlivier Rascol, Jean-Philippe Azulay, Olivier Blin, et al.
Parkinsonism & Related Disorders|January 19, 2016
Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literatureWassilios G Meissner, Chloé Laurencin, Christine Tranchant, et al.
Clinical Neurology and Neurosurgery|May 3, 2016
Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsyLaurène Leclair-Visonneau, Tiphaine Rouaud, Bérangère Debilly, et al.
Brain Stimulation|January 5, 2024
Lessons from multitarget neurostimulation in isolated dystonia: Less is more?Marie-Charlotte Cuartero, David Grabli, Emmanuel Flamand-Roze, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2024
Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic DyskinesiaThomas Wirth, Emmanuel Roze, Clarisse Delvallée, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Neurology|December 28, 2013
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trialFabienne Ory-Magne, Jean-Christophe Corvol, Jean-Philippe Azulay, et al.
Neurology|January 22, 2016
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesiaHélène Pouclet-Courtemanche, Tiphaine Rouaud, Stephane Thobois, et al.
Pageof 11

Showing results (71-80 of 107) with videos related to

Sort By:
Pageof 11
Neurobiology of Aging|June 5, 2012
EIF4G1 in familial Parkinson's disease: pathogenic mutations or rare benign variants?Suzanne Lesage, Christel Condroyer, Stephan Klebe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2010
Orodispersible sublingual piribedil to abort OFF episodes: a single dose placebo-controlled, randomized, double-blind, cross-over studyOlivier Rascol, Jean-Philippe Azulay, Olivier Blin, et al.
Parkinsonism & Related Disorders|January 19, 2016
Outcome of deep brain stimulation in slowly progressive multiple system atrophy: A clinico-pathological series and review of the literatureWassilios G Meissner, Chloé Laurencin, Christine Tranchant, et al.
Clinical Neurology and Neurosurgery|May 3, 2016
Randomized placebo-controlled trial of sodium valproate in progressive supranuclear palsyLaurène Leclair-Visonneau, Tiphaine Rouaud, Bérangère Debilly, et al.
Brain Stimulation|January 5, 2024
Lessons from multitarget neurostimulation in isolated dystonia: Less is more?Marie-Charlotte Cuartero, David Grabli, Emmanuel Flamand-Roze, et al.
Neurobiology of Disease|July 21, 2018
Deep brain stimulation does not enhance neuroinflammation in multiple system atrophyMiguel Lopez-Cuina, Pierre-Olivier Fernagut, Marie-Hélène Canron, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 4, 2024
Rare Missense Variants in KCNJ10 Are Associated with Paroxysmal Kinesigenic DyskinesiaThomas Wirth, Emmanuel Roze, Clarisse Delvallée, et al.
Plos One|January 24, 2014
Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohortGaëlle Désaméricq, Guillaume Dolbeau, Christophe Verny, et al.
Neurology|December 28, 2013
Withdrawing amantadine in dyskinetic patients with Parkinson disease: the AMANDYSK trialFabienne Ory-Magne, Jean-Christophe Corvol, Jean-Philippe Azulay, et al.
Neurology|January 22, 2016
Long-term efficacy and tolerability of bilateral pallidal stimulation to treat tardive dyskinesiaHélène Pouclet-Courtemanche, Tiphaine Rouaud, Stephane Thobois, et al.
Pageof 11